Australia's most trusted
source of pharma news
Friday, 13 March 2026
Friday, 13 March 2026
Subscribe
Login
Minister wins blockbuster price cut case
This pharma has failed in a bid to protect $164 million in reimbursements from taking a follow-on statutory price reduction haircut, with a court ruling in favour of the Minister for Health.
PBS is "like handwriting letters"
AbbVie GM tells a future leadership summit that PBS processes are stuck deep in the past, blocking access to scientific advances
TODAY
Pain Institute launches in Australia
Bringing together clinical and academic expertise to develop ways to support HCPs and patients improve pain outcomes
TODAY
CEO flying in for Aussie TV spot
In a televised address, Novo CEO Mike Doustdar will appeal to Australia to take a leadership role in the global effort to prevent chronic disease
12 March
New PBS drug pulls out of Australia
Long time listing... short time listed. First-in-class drug subsided for just half the time the sponsor spent getting it listed
11 March
Hidden hazards of Hybrid Work
The "sugar hit" of working from home could be fading for some with boundary erosion sending workloads and work hours soaring
11 March
Who forgot to pay the patent renewal?
A pharma has narrowly avoided losing patent exclusivity after a chain of outsourcing saw a breakdown in communication
10 March
Latest Jobs
Regulatory Affairs SpecialistAccount ManagerBusiness Development Manager | Community CareDirector of OperationsPharmacovigilance AssociateRegulatory Affairs SpecialistSenior Recruitment ConsultantPharmacy Storeperson23 more...
Pharma in Focus Jobs
Marketing & Communications (1)
Sales & Customer Relations (12)
- Account Manager - Sydney
- Business Development Manager | Community Care - Queensland
- Pharmaceutical Sales Representative - Sydney
- Devices Account Manager - Sydney
- Customer Service Representative - Pemulwuy
- Customer Service Representative - St Leonards
- Pharmaceutical Sales Representative - Brisbane
- Customer Service Specialist - Frenchs Forest
- Customer Service Representative - St Leonards
- Territory Manager - Capital Equipment - Melbourne
- Junior Accountant - Sydney
- Territory Manager - Melbourne
Clinical & Medical, R&D (3)
- Senior Clinical Project Manager - Tokyo, Japan
- Senior Manager, Clinical Operations (Japan) - Tokyo, Japan
- Quality & Medical Operations Specialist - Sydney
Regulatory, Pharmacovigilance & QA (8)
- Regulatory Affairs Specialist - Lane Cove
- Pharmacovigilance Associate - Sydney
- Regulatory Affairs Specialist - Glenorie
- Associate Director Regulatory Operations (Japan) - Tokyo, Japan
- Senior Manager, Regulatory Affairs Operations - Tokyo, Japan
- Regulatory & Quality Manager - Melbourne
- Senior Quality Associate - New South Wales
- Quality & Medical Operations Specialist - Sydney
Devices (1)
Executive Roles (4)
- Director of Operations - Melbourne
- Associate Director Regulatory Operations (Japan) - Tokyo, Japan
- Senior Manager, Clinical Operations (Japan) - Tokyo, Japan
- Senior Manager, Regulatory Affairs Operations - Tokyo, Japan
Other (8)
- Senior Recruitment Consultant - Sydney
- Pharmacy Storeperson - Toongabbie
- Warehouse Assistant - Eight Mile Plains
- Materials Planner - North Ryde
- Procurement Specialist - New South Wales
- Finance & Administration Officer - Macquarie Park
- Re-manufacturing Operator - New South Wales
- Warehouse Assistant - Blacktown
US backs drug with $21M injection
US government agency backs Aussie-led project developing the first oral therapeutic for restoring gut lymphatic function
12 March
Is pharma simply too risk averse?
Australia pharma leaders are worried that industry is too cautious when it comes to driving cross-functional digital transformation
12 March
New front in $100M legal fight
Generic company takes a new tack in its bid to launch into a lucrative market, claiming a patent extension should never have been granted
12 March
Heart drug launches in Australia
The fast-acting, short half-life drug gives HCPs greater precision in treating people with elevated heart rates in the acute setting
12 March
Pharma ups its game in hot market
Company adds self-injectable version of its treatment being considered by the reimbursement committee this week
11 March
Report exposes nuclear meds crisis
Industry stakeholders unite in call for urgent reform of Australia's nuclear medicines sector, with a National Action Plan launched
11 March
CSL's $1.5 billion US expansion
The local giant is investing $1.5 billion in manufacturing capacity to meet growing demand in rare diseases
11 March
Homegrown CAR T therapy debuts
An Australian team is hoping to crack the blood cancer market, with other candidates in the pipeline for solid organ cancers
10 March
17 new drug labels under review
TGA reviewing new indications spanning a range of therapeutic areas, including cardiovascular, oncology, and immunology
10 March
GM's access call gets personal
Cancer med needed by a close family member not subsidised on the PBS - an "unthinkable" situation a decade ago
10 March
Obesity rival plays the long game
Roche partner says placebo-like tolerability will keep patients on the treatment for longer, eclipsing concerns about lesser weight loss
10 March
11 new drugs hit the TGA's desk
Pegged blockbusters, including a once-daily oral GLP-1 drug and an oral plaque psoriasis treatment are among those under TGA review
9 March
Who's been gifted a long weekend?
A day off for employees to prioritise their own health and support the women in their lives, in honour of International Women's Day
9 March
New jobs: Who's gone where?
The job shuffle continues across Australian pharma with departures, new hires, secondments and promotions across industry
9 March